Plain-English translation of NCT06218420 on ClinicalTrials.gov ↗ ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing stereotactic body radiotherapy (SBRT)—a high-precision radiation treatment that delivers a focused, powerful dose directly to liver tumors—for people with liver cancer who are waiting for a liver transplant. The goal is to see whether this treatment can safely keep the cancer from getting worse during the waiting period, so patients can reach their transplant in the best possible condition.
Many patients with liver cancer wait 6 to 12 months for a liver transplant, which is the best cure available. During that waiting time, the cancer can grow and spread, making transplantation less likely to succeed. This trial exists to see if this focused radiation treatment can safely hold the cancer in check while patients wait, giving them a better chance at a successful transplant.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive stereotactic body radiotherapy—a type of high-precision radiation delivered to your liver tumors over a short period of time. The treatment is carefully planned and targeted to minimize damage to healthy liver tissue. Researchers will follow your progress through imaging scans and blood tests to see whether the radiation successfully controls your cancer while you wait for your transplant.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France